Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell lines
Yvonne Bader, Thomas Szekeres(Medical University of Vienna), Georg Krupitza(Medical University of Vienna), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Johannes Hartmann(University of Oxford), Sibylle Madlener(Comprehensive Cancer Center Vienna), Michael Grusch(Comprehensive Cancer Center Vienna), Rudolf-Giesbert Alken, Nicole A. Heller, Philipp Saiko(Ludwig Boltzmann Institute Applied Diagnostics), Monika Fritzer‐Szekeres(Vienna General Hospital), Susanne Maier(Vienna General Hospital), Leopold Oehler
Cited by 19
Related Papers
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
|PLoS ONE|2011|437
Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice
|Science|2018|422
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
|Annals of Oncology|2013|403
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
|Nature Medicine|2022|395
Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure–activity relationship
|Biochemical Pharmacology|2005|303